Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cell Death and Differentiation|November 22, 2014
Regulation of c-Myc protein stability by proteasome activator REGγS Li, C Jiang, J Pan, et al.
Plant Biology (Stuttgart, Germany)|August 11, 2020
The morphological and physiological basis of delayed pollination overcoming pre-fertilization cross-incompatibility in NicotianaS-Y Chen, J-W Zhang, X-M Wei, et al.
Cancer Research|July 19, 2014
Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLCJeremy H Tchaicha, Esra A Akbay, Abigail Altabef, et al.
Bioinformatics (Oxford, England)|August 7, 2012
An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detectionXingbin Wang, Dongwan D Kang, Kui Shen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 21, 2015
Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after ParturitionTiffany A Katz, Serena G Liao, Vincent J Palmieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscapeD J Vis, J Lewin, R G Liao, et al.
Cancer Research|June 22, 2013
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinomaRachel G Liao, Joonil Jung, Jeremy Tchaicha, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|October 20, 2024
[Prognosis of different hemodynamic classifications in patients with pulmonary hypertension due to left heart disease]Y Tang, Y P Shi, L Chen, et al.
Molecular Cancer Therapeutics|April 15, 2018
RAS-MAPK Reactivation Facilitates Acquired Resistance in <i>FGFR1</i>-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK BlockadeBruno Bockorny, Maria Rusan, Wankun Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Pageof 13